HKEX: 3681 - SinoMab BioScience Limited

Yield per half year: -0.813%
Dividend yield: 0.00%
Sector: Healthcare

Reporting SinoMab BioScience Limited

Reports

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023
Финансовый отчет link link link link link


Capitalization

IFRS
Reporting Annual Quarterly
2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Капитализация, млрд ¥
4.27 3.52 3.51 2.2 1.69 1.5 3.04 -16.92
Выручка, млрд ¥
0.0259 0.0014 0.0014 0.0136 -76.75
Чистая прибыль, млрд ¥
-0.048 -0.0836 -0.2763 -0.1226 -0.2882 -0.2509 -0.2431 -0.2431 -0.2362 -2.53
EV, млрд ¥
0.0188 2.76 2.77 1.84 1.84 1.85 214.53
EBIT, млрд ¥
-0.0396 -0.0548 -0.2759 -0.1226 -0.3059 -0.2286 -0.1976 33.06
EBITDA, млрд ¥
-0.0383 -0.0531 -0.2674 -0.1202 -0.2824 -0.2218 -0.2512 -0.1890 33.10
Баланс стоимость, млрд ¥
-0.051 0.0274 1.13 0.987 0.6802 0.4499 0.2956 0.2956 0.7085 -23.52
FCF, млрд ¥
-0.041 -0.0496 -0.2648 -0.2337 -0.1471 -0.3664 -0.2377 -0.2377 -0.2499 -2.14
Операционный денежный поток, млрд ¥
-0.0402 -0.0468 -0.2225 -0.1413 -0.1471 -0.2654 -0.1338 -0.1338 -0.1820 -9.67
Операционная прибыль, млрд ¥
-0.0396 -0.0548 -0.2759 -0.1627 -0.3059 -0.2418 -0.2296 -0.2296 -0.2432 -3.61
Операционные расходы, млрд ¥
0.0396 0.0548 0.2759 0.1627 0.3318 0.2286 0.2309 0.2309 0.2460 -3.50
CAPEX, млрд ¥
0.000823 0.0027 0.0423 0.076 0.1982 0.0295 0.1039 0.1039 0.0900 19.69


Balance sheet

IFRS
Reporting Annual Quarterly
2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Наличность, млрд ¥
0.0661 0.0415 1.2 0.8104 0.563 0.3053 0.2037 0.2037 0.6165 -29.86
Short Term Investments ¥
0.0468 0.0931 0.0269 0.031 0.031 0.0495 -9.78
Total Receivables ¥
0.000259 0.0003 0.00
Total Current Assets ¥
0.1268 0.0503 1.22 0.9344 0.5957 0.3948 0.2702 0.2702 0.6830 -26.03
Чистые активы, млрд ¥
0.0347 0.0384 0.0422 0.1459 0.3562 0.429 0.4471 0.4858 0.2841 60.33
Активы, млрд ¥
0.1616 0.0888 1.28 1.13 1.04 0.8903 0.8478 0.8478 1.04 -7.91
Short Term Debt ¥
0.0468 0.01 0.005 0.0304 0.0666 0.0666 0.0318 7.31
Long Term Debt ¥
0.033 0.0203 0.0555 0.1938 0.2749 0.3248 0.3248 0.1739 74.11
Задолженность, млрд ¥
0.2126 0.0614 0.1522 0.1425 0.3614 0.4404 0.5522 0.5522 0.3297 29.40
Чистый долг, млрд ¥
0.1459 0.0188 -1.15 -0.7499 0.1877 0.1877 -0.3095 5.17
Долг, млрд ¥
0.0603 0.0536 0.0605 0.3914 0.3572 0.1415 59.62
Interest income ¥
0.0123 0.0282 0.000319 0.0173 0.0167 0.0104 0.0062 0.0102 81.02
Расходы на обслуживание долга ¥
0.003 0.0023 0.0024 0.0058 0.0282 0.0066 0.0066 0.0091 23.47
Чист. проц. доходы, млрд ¥
-0.0029 -0.0029 0.000655 0.0149 0.0109 0.0046 -0.000408 0.0068 0.0061 -190.97
Амортизация, млрд ¥
0.0013 0.0017 0.0085 0.0038 86.99
Себестоимость, млрд ¥
0.000117 0.000743 0.000943 0.000943 0.0006 100.50


Share

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS -0.0831 -0.2746 -0.1218 -0.2864 -0.2424 -0.2349 -0.2349 -0.2320 -3.07
Цена акции ао 3.54 4.6 2.86 1.81 1.68 1.09 1.22 1.22 1.73 -15.67
Число акций ао, млн 1006.24 1006.24 836.65 1006.24 1006.24 1006.24 1034.92 1034.92 1034.92 1017.71 0.56
FCF/акцию -0.0408 -0.0593 -0.2631 -0.2322 -0.1462 -0.354 -0.2297 -0.2297 -0.2450 -2.68


Efficiency

IFRS
Reporting Annual Quarterly
2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 94.16 -305.08 -24.41 -12.42 -42.37 -49.89 -65.22 -65.22 7.91 -38.8620 21.72
ROA, % -29.68 -94.14 -21.51 -10.85 -27.67 -28.81 -27.97 -27.97 5.02 -23.3620 5.39
ROS, % -1112.16 -17810.33 -17810.33 -17810.33 -17810.33 8.52 -13635.7875 100.04
ROCE, % 77.71 -199.95 -24.37 -12.42 -44.96 -31.54 0 0 0.37 -62.6480 -30.88
Ebit margin, % -1180.32 0 0 -1180.3200 0.00
Рентаб EBITDA, % -1089.7 -18402.93 -18402.93 -7.55 -9746.3150 310.95
Чистая рентаб, % -1112.16 -17810.33 -17810.33 8.53 -9461.2450 300.18
Operation Margin, % -1180.32 -16818.68 -16818.68 -16818.68 -16818.68 12.04 -12909.0900 94.29
Доходность FCF, % -6.2 -6.65 -4.19 -18.88 -14.09 -10.0020 17.84


Coefficients

IFRS
Reporting Annual Quarterly
2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-15.45 -28.67 -12.18 -7.74 -6.94 22.69 -14.1960 -14.79
P/BV
3.77 3.56 5.16 3.74 5.61 5.61 3.03 4.37 8.27
P/S
135.51 1213.88 1213.88 8.76 674.70 199.30
P/FCF
-16.12 -15.04 -23.88 -5.3 -7.1 -6.31 -6.31 -6.31 -3.66 -9.7800 -23.37
E/P
-0.0647 -0.0349 -0.0821 -0.1293 -0.1441 -0.1621 -0.1621 -0.1621 0.04 -0.1359 14.57
EV/EBITDA
-0.3533 -10.31 -23.01 -5.89 -5.04 -11.2244 302.34
EV/EBIT
-8.53 -25.7 0 0 0 -17.1150 73.58
EV/S
1351.42 1351.42 1351.42 1351.42 32.54 1351.42 0.00
EV/FCF
-8.89 -11.84 -7.76 -7.76 -7.76 -7.76 4.53 -8.8020 -2.68
Debt/EBITDA
-0.2005 -0.5031 -1.42 -1.42 -1.42 -1.42 0.71 -0.9927 47.92
Netdebt/Ebitda
-3.8 -0.3533 4.29 6.24 0 -0.7473 -0.7473 -0.7473 -0.56 1.74 16.16
Debt/Ratio
0.0418 0.0535 0.4617 0.4213 0.4213 0.4213 0.10 0.2799 58.74
Debt/Equity
0.0474 0.0613 1.32 0.7353 0.7353 0.7353 0.74 0.5799 73.04
Debt/Net Income
-0.1941 -0.4932 -1.61 -1.47 -1.47 -1.47 0.78 -1.0475 49.92
Бета
-1.84 -0.4235 0.3359 0.3359 0.31 -0.6425 -156.73
Индекс Альтмана
1.22 2.24 2.24 2.24 5.32 1.90 22.45


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 2.64
Дивиденды / прибыль, %
0 21.26


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 CAGR 5
Персонал, чел
282 0.00